Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)
Titel:
Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)
Auteur:
Fasching, P.A. Link, T. Hauke, J. Seither, F. Jackisch, C. Klare, P. Schmatloch, S. Hanusch, C. Huober, J. Stefek, A. Seiler, S. Schmitt, W.D. Uleer, C. Doering, G. Rhiem, K. Schneeweiss, A. Engels, K. Denkert, C. Schmutzler, R.K. Hahnen, E. Untch, M. Burchardi, N. Blohmer, J.-U. Loibl, S.